Expression of transforming growth factor alpha and epidermal growth factor receptor in human bladder cancer

REFERENCES

• Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995; 19: 183–232.
   PubMed Web of Science ®Google Scholar
• Earp HS, Dawson TL, Li X, Yu H. Heterodimer-ization and functional interaction between EGF receptor family members: a new signaling para-digm with implications for breast cancer research. Breast Cancer Res Treat 1995; 35: 115–32.
   PubMed Web of Science ®Google Scholar
• Gavrilovic J, Moens G, Thiery JP, Jouanneau J. Expression of transfected transforming growth factor alpha induces a motile fibroblast-like phenotype with extracellular matrix degrading potential in a rat bladder carcinoma cell line. Cell Regul 1990; 1: 1003–14.
   PubMedGoogle Scholar
• Ravery V, Colombel M, Popov Z, Bastuji S, Patard JJ, Bellot J, Abbou CC, Fradet Y, Chopin DK. Prognostic value of epidermal growth factor receptor, T138 and T43 expression in bladder cancer. Br J Cancer 1995; 71: 196–200.
   Google Scholar
• Mellon JK, Cook S, Chambers P, Neal DE. Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor. Br J Cancer 1996; 73: 654–8.
   PubMed Web of Science ®Google Scholar
• Messing EM, Hanson P, Ulrich P, Erturk E. Epidermal growth factor interactions with normal and malignant urothelium: in vivo and in situ studies. J Urol 1987; 138: 1329–35.
   PubMed Web of Science ®Google Scholar
• Chow NH, Liu HS, Yang HB, Chan SH, Su U. Expression patterns of erb-B receptor family in normal urothelium and transitional cell carci-c noma. An immunohistochemical study. Virchows Arch 1997; 430: 461–6.
   Google Scholar
• Chow NH, Liu HS, Lee El, Chang CJ, Chan SH, Cheng HL, Tzai TS, Lin JS. Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer. Anticancer Res 1997; 17: 1293–6.
   PubMed Web of Science ®Google Scholar
• Mellon K, Wright C, Kelly P, Horne CH, Neal DE. Long-term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol 1995; 153: 919— 25.
   Google Scholar
• Messing EM. Clinical implications of the expres-sion of epidermal growth factor receptors in human transitional cell carcinoma. Cancer Res 1990; 50: 2530–7.
   PubMed Web of Science ®Google Scholar
• Neal DE, Smith K, Fennelly JA, Bennett MK, Hall RR, Harris AL. Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand binding. J Urol 1989; 141: 517–21.
   PubMedGoogle Scholar
• Neal DE, Marsh C, Bennett MK, Abel PD, Hall RR, Sainsbury JR, Harris AL. Epidermal growth factor receptors in human bladder cancer: com-parison of invasive and superficial tumours. Lancet 1985; 1: 366–8.
   Google Scholar
• Ravery V, Grignon D, Angulo J, Pontes E, Montie J, Crissman J, Chopin D. Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erb-B2 in the progression of invasive bladder cancer. Urol Res 1997; 25: 91–7.
   Google Scholar
• Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL. The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 1990; 65: 1619–25.
   PubMed Web of Science ®Google Scholar
• Berger MS, Greenfield C, Gullick WJ, Haley J, Downward J, Neal DE, Harris AL, Waterfield MD. Evaluation of epidermal growth factor receptors in bladder tumours. Br J Cancer 1987; 56: 533–7.
   PubMed Web of Science ®Google Scholar
• Wood DP Jr, Fair WR, Chaganti RS. Evaluation of epidermal growth factor receptor DNA ampli-fication and mRNA expression in bladder cancer. J Urol 1992; 147: 274–7.
   Google Scholar
• Chow NH, Tzai TS, Cheng PE, Chang CJ, Lin JS, Tang MJ. An assessment of immunoreactive epidermal growth factor in urine of patients with urological diseases. Urol Res 1994; 22: 221–5.
   PubMedGoogle Scholar
• Fuse H, Mizuno I, Sakamoto M, Katayama T. Epidermal growth factor in urine from the patients with urothelial tumors. Urol Int 1992; 48: 261–4.
   PubMedGoogle Scholar
• Kristensen JK, Lose G, Lund F, Nexo E. Epidermal growth factor in urine from patients with urinary bladder tumors. Eur Urol 1988; 14: 313 — 4.
   PubMedGoogle Scholar
• Chomczynski P, Sacchi N. Singlestep method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987; 162: 156–9.
   PubMed Web of Science ®Google Scholar
• Sambrook J, Fritsch EF, Maniatiatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Lab, 1989; 7.01-7.87.
   Google Scholar
• Thogersen VB, Bross P, Gregersen N, Nexo E. Quantitative analysis of the human epidermal growth factor receptor messenger RNA using reverse transcription-PCR a methodological study of imprecision. Clin Chem 1998; 44: 1344 — 6.
   PubMedGoogle Scholar
• Haley J, Whittle N, Bennet P, Kinchington D, Ullrich A, Waterfield M. The human EGF receptor gene: structure of the 110 kb locus and identification of sequences regulating its transcrip-tion. Oncogene Res 1987; 1: 375–96.
   PubMedGoogle Scholar
• Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epider-moid carcinoma cells. Nature 1984; 309: 418–25.
   PubMed Web of Science ®Google Scholar
• Lichtsteiner S, Tjian R. Cloning and properties of the Caenorhabditis elegans TATA box binding protein. Proc Natl Acad Sci USA 1993; 90: 9673–7.
   PubMedGoogle Scholar
• Qian JF, Feingold J, Stoll C, May E. Transform-ing growth factor-alpha: characterization of the BamHI, RsaI, and TaqI polymorphic regions. Am J Hum Genet 1993; 53: 168–75.
   PubMedGoogle Scholar
• Christensen ME, Engbaek F, Therkildsen MH, Bretlau P, Nexo E. A sensitive enzymelinked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations. Br J Cancer 1995; 72: 1487–93.
   Google Scholar
• Jorgensen PE, Vinter Jensen L, Nexo E. An immunoassay designed to quantitate different molecular forms of rat urinary epidermal growth factor with equimolar potency: application on fresh rat urine. Scand J Clin Lab Invest 1996; 56: 25–36.
   PubMed Web of Science ®Google Scholar
• Sauter G, Haley J, Chew K, Kerschmann R, Moore D, Carroll P, Moch H, Gudat F, Mihatsch MJ, Waldman F. Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer 1994; 57: 508–14.
   PubMed Web of Science ®Google Scholar
• Lipponen PK, Eskelinen MJ. Expression of p52 protein in transitional cell bladder tumours. J Pathol 1994; 173: 327–32.
   PubMedGoogle Scholar
• Witjes JA, Umbas R, Debruyne FM, Schalken JA. Expression of markers for transitional cell carci-noma in normal bladder mucosa of patients with bladder cancer. J Urol 1995; 154: 2185–9.
   PubMedGoogle Scholar
• Wright C, Mellon K, Johnston P, Lane DP, Harris AL, Horne CH, Neal DE. Expression of mutant p53, c-erb-B2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 1991; 63: 967–70.
   Google Scholar
• Moriyama M, Akiyama T, Yamamoto T, Kawamoto T, Kato T, Sato K, Watanuki T, Hikage T, Katsuta N, Mori S. Expression of c-erb-B2 gene product in urinary bladder cancer. J Urol 1991; 145: 423–7.
   PubMed Web of Science ®Google Scholar
• Press MF, Hung G, Godolphin W, Slamon DJ. Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expres-sion. Cancer Res 1994; 54: 2771–7.
   PubMed Web of Science ®Google Scholar
• Gleave ME, Hsieh JT, Wu HC, Hong SJ, Zhau HE, Guthrie PD, Chung LW. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma. Cancer Res 1993; 53: 5300–7.
   Google Scholar
• Wolf H. Neal DE, editors. Tumours in urology. Tumour progression in superficial bladder cancer. London: Springer-Verlag, 1994; 3: 47–64.
   Google Scholar
• Vollmer RT, Humphrey PA, Swanson PE, Wick MR, Hudson ML. Invasion of the bladder by transitional cell carcinoma: its relation to histolo-gic grade and expression of p53, MIB1, c-erb B2, epidermal growth factor receptor, and bc1-2. Cancer 1998; 82: 715–23.
   Google Scholar
• Turkeri LN, Erton ML, Cevik I, Akdas A. Impact of the expression of epidermal growth factor, transforming growth factor alpha, and epidermal growth factor receptor on the prognosis of super-ficial bladder cancer. Urology 1998; 51: 645–9.
   PubMedGoogle Scholar